Investment Conference
Miami 2026 Edition

GOA Therapeutics

Biotech

GOA Therapeutics is a biotechnology company developing first-in-class treatments for acute alcohol intoxication and poisoning. Its lead drug candidate, GOA26, is designed to rapidly reduce blood alcohol concentration, addressing a major unmet need in emergency medicine. Backed by over a decade of research, successful preclinical testing, and more than 30 patent filings worldwide, GOA aims to improve patient outcomes, reduce alcohol-related fatalities, and lower healthcare costs.

Ever:Red

FoodTech

Ever:Red is a FoodTech company developing sustainable, plant-based alternatives to natural pigments used in food, beverages, cosmetics, and pharmaceuticals. Its proprietary biotechnology platform uses duckweed to produce carminic acid, the key ingredient in carmine red pigment, without relying on insect-derived production. Built on research from the Weizmann Institute of Science, Ever:Red aims to provide scalable, ethical, and cost-effective color solutions while expanding its technology to produce a broader range of high-value natural pigments.

Guardz

Cybersecurity

Guardz is a cybersecurity company focused on providing innovative, AI-driven security solutions tailored for managed service providers (MSPs). The platform offers a range of features including email security, cyber awareness training, cloud data protection, and AI-powered phishing simulations, designed to enhance the security posture of small and medium-sized businesses.

Etrog Systems

MedTech

Etrog Systems is a MedTech company developing wearable biosensor technology to transform patient monitoring and connected healthcare. Its flagship MultiVS platform continuously tracks more than 10 vital signs through a single wearable device, providing healthcare teams with a unified view of patient health across hospitals, rehabilitation facilities, and home care. By enabling continuous monitoring and seamless data sharing, Etrog aims to improve patient outcomes, reduce healthcare costs, and support more efficient care delivery.

Cytora

Biotech

Cytora is a biotechnology company developing innovative stem cell therapies to address serious diseases and unmet medical needs. Its proprietary platform uses placenta-derived stem cells to create scalable, off-the-shelf treatments that harness the body's natural regenerative and immunomodulatory processes. By combining the therapeutic potential of stem cells with standardized manufacturing, Cytora aims to make advanced regenerative treatments more accessible, cost-effective, and commercially scalable.

Tracells

Biotech

Tracells is a biotechnology company developing non-invasive diagnostic solutions for inflammatory bowel diseases (IBD). Its proprietary platform combines RNA analysis of intestinal cells found in stool samples with AI-powered algorithms to identify the severity, location, and molecular characteristics of intestinal inflammation. Originating from research at the Weizmann Institute, Tracells aims to reduce reliance on invasive colonoscopies, enable personalized treatment decisions, and improve disease monitoring while lowering healthcare costs.